학술논문
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy
Document Type
Article
Author
Source
In Cancer Letters 28 December 2014 355(2):217-223
Subject
Language
ISSN
0304-3835